Our company proudly showcased our advancements in Endocrinology, Diabetes, and Metabolism Hong Kong’s exhibition. A highlight of our presentation was Fibroscan, a well-established tool used for over 20 years to assess fatty liver and liver stiffness. This technology is supported by robust data and is widely recognized in numerous international guidelines for managing and monitoring patients with metabolic syndrome. To enhance participant engagement, we set up a demo unit, allowing attendees to experience Fibroscan examination firsthand. This interactive approach not only educated visitors about the importance of liver health but also demonstrated our commitment to effective solutions in patient care.
